Showing results (741-750 of 778) with videos related to

Sort By:
Pageof 78
Haematologica|May 13, 2014
Intravenous busulfan for autologous stem cell transplantation in adult patients with acute myeloid leukemia: a survey of 952 patients on behalf of the Acute Leukemia Working Party of the European Group for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Norbert-Claude Gorin, et al.
Leukemia|November 1, 2024
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemiaAvichai Shimoni, Christophe Peczynski, Myriam Labopin, et al.
Journal of Neuro-Oncology|June 21, 2021
A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade gliomaKeren Porper, Yael Shpatz, Luba Plotkin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2012
Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experienceS Le Gouill, N Kröger, N Dhedin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2010
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patientsMichal J Besser, Ronnie Shapira-Frommer, Avraham J Treves, et al.
Leukemia|September 30, 2005
Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)M Aoudjhane, M Labopin, N C Gorin, et al.
Blood|February 26, 2004
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantationNicolaus Kröger, Georgia Schilling, Hermann Einsele, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2004
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myelomaNicolaus Kröger, Jose A Perez-Simon, Han Myint, et al.
Emerging Infectious Diseases|April 3, 2002
Listeria monocytogenes infection in Israel and review of cases worldwideYardena Siegman-Igra, Rotem Levin, Miriam Weinberger, et al.
European Journal of Haematology|June 2, 2012
Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMTArnon Nagler, Myriam Labopin, Avichai Shimoni, et al.
Pageof 78